The manufacturer of the Xarelto, an anti-coagulant drug, is being sued by a woman from A Kentucky through a lawsuit filed by her personal injury lawyer at the Common Pleas Courts in Philadelphia. Two years ago, she alleged that she suffered acute gastrointestinal and internal bleeding after taking the prescription drug for atrial fibrillation. 

The plaintiff was identified as Virginia G. Stuntebeck, who claimed that she was hospitalized mid-February last year. It happened one year-and-a-half after she started using the drug as prescribed by her health care provider.

Based on law suit, the plaintiff was prescribed an anti- coagulant drug called Xarelto to decrease the danger and treat stroke and systemic embolism of patients suffering from atrial non-valvular fibrillation. It was routinely advertised as a one size fits all drugs.

The makers of the drug failed to inform patients requiring a blood-thinning agent, as well as their healthcare providers that those ingesting the drug must be continuously monitored.

The lawsuit blamed the defendants of creating a new drug that is not safe compared with another drug called warafin although Xarelto may be slightly easier to use and administer that physicians were convinced of the ease and convenience of using this anticoagulant for vigorous marketing and promotion made by the company. However, defendants ignored the patient’s safety.

The Xarelto marketing materials suggested that the drug was a therapeutic simplification and therapeutic progress for patients are no longer required to undergo a periodic monitoring with blood tests; furthermore, there was no need for any dietary restrictions.

Xarelto was first approved by the U.S. Food and Drug Administration in July 2011.

The lawsuit alleged that the drug companies vigorously advertised the drug in the online marketing of their website, and excessive video ads without considering the accuracy and unintended consequences of their misleading commercials for the sake profits.

Their successful intensive marketing resulted to more than 130,000 Xarelto prescriptions written in the U.S. during the first three months of 2012. The result was large profits for the drug makers.

The suit stated that people prescribed Xarelto were told they do not need blood monitoring or any doctor follow-ups, although there were already concerns about the risk of stroke and blood clots while taking the pharmaceutical.

Around 968 cases were suspected as undesirable side effects based on a report from Germany that included 72 deaths during the first eight months of 2013.

The defendants hid their knowledge that Xarelto can lead to life threatening irreversible bleeding from the plaintiff, consumers in general and the medical community.

The lawsuit contains the following complaints: (1) breach of implied and express warranties; (2) fraud; (3) product liability; (4) unreasonable failure to remove the drug from the market; (5) unreasonable marketing of a dangerous drug;  and (6) violation of consumer protection laws.

Some of the biggest names in the drug industry were named defendants in the complaint are: (1) Bayer Corp.; (2) Development LLC.; (3) Janssen Pharmaceuticals; and (4) Johnson & Johnson Research.

Accident victims have rights. If you were injured due to dangerous drugs, contact an experienced Philadelphia Medical Malpractice Lawyer now for free consultation. He will protect the rights of you and your loved ones. You may be entitled to financial compensation for economic damages, as well as pain and suffering.

Source: Penn record Com